A woman has filed a lawsuit in the U.S. District Court of Wyoming, alleging that she suffered a pulmonary embolism because she took the birth control drug Yaz.
Yaz, or Yasmin and Ocella contain combinations of estrogen and progesterone. According to the woman’s lawsuit, she was not notified of the dangers associated with the drug, which her doctor allegedly said caused her to have a pulmonary embolism in May 2012.
Aside from pulmonary embolisms, Yaz has been linked to heart attacks, deep vein thrombosis, strokes, blood clots, gallbladder disease and death.
In July 2003, the US Food and Drug Administration (FDA) released a warning letter after Yaz’s manufacturer, Bayer, started promoting the drug over other forms of birth control. “[The] FDA is not aware of substantial evidence of substantial clinical experience demonstrating that Yasmin is superior to other COCs or that the drospierenone in Yasmin is clinically beneficial,” the FDA said. “On the contrary, [the] FDA is aware of the added clinical risks associated with drospierenone.”
COC means “combination oral contraceptive”. Drospierenone is a synthetic hormone used in birth control pills. Since the agency’s warning, it has had to repeatedly reprimand Bayer for advertising issues relating to Yaz. Bayer advertising is known to minimize the negative consequences of taking the drug, which is now the highest-selling oral contraceptive pill in the United States.
Our pharmaceutical drug and device attorneys have fought for hundreds of plaintiffs who have been injured taking Yaz, Yasmin and Ocella. If you have been injured, contact our by Yaz attorneys by calling 888-841-9623. We fight businesses that falsely advertise their products while ignoring the safety of consumers.
Zoll, Kranz & Borgess, LLC – Class Action Lawyers
ZKB’s ‘Did You Know?’: It is estimated that more than 12 million woman in the U.S. have used Yaz or Yasmin as a contraceptive.